Skip to content

Clinical trials

Withdrawn Phase 2 Lymphoma, Mantle-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Phase: Phase 2 Status: Withdrawn Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20071
20101
20141
20151
20161
20191
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
Masonic Cancer Center, University of Minnesota2
Academic and Community Cancer Research United1
Burzynski Research Institute1
Hoag Memorial Hospital Presbyterian1
James Blachly1
The Methodist Hospital Research Institute1
University of California, San Francisco1
University of Medicine and Dentistry of New Jersey1
University of Michigan Rogel Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell13
Leukemia, Lymphocytic, Chronic, B-Cell8
Burkitt Lymphoma7
Lymphoma, B-Cell, Marginal Zone7
Lymphoma, Follicular6
Lymphoma, Large B-Cell, Diffuse6
Lymphoma, Non-Hodgkin6
Lymphoma, Large-Cell, Immunoblastic5
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Waldenstrom Macroglobulinemia5

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.